Inmune Bio, Inc.
(NASDAQ : INMB)

( )
INMB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -0.07%67.511.0%$1047.35m
BIIBBiogen, Inc. 3.00%343.001.5%$720.34m
AMGNAmgen, Inc. -0.62%222.091.3%$585.61m
ILMNIllumina, Inc. 2.59%298.923.5%$440.19m
REGNRegeneron Pharmaceuticals, Inc. -0.45%397.742.6%$385.35m
VRTXVertex Pharmaceuticals, Inc. -0.74%242.011.9%$346.26m
ALXNAlexion Pharmaceuticals, Inc. 0.00%102.562.0%$208.61m
EXASEXACT Sciences Corp. 3.61%98.1824.0%$165.42m
AAgilent Technologies, Inc. 0.41%86.191.6%$152.04m
SGENSeattle Genetics, Inc. -0.13%118.076.1%$116.25m
MRNAModerna, Inc. 0.74%19.140.0%$112.10m
INCYIncyte Corp. -0.57%78.002.5%$100.64m
XLRNAcceleron Pharma, Inc. -0.48%93.666.1%$99.78m
SRPTSarepta Therapeutics, Inc. 0.31%125.4214.6%$97.24m
BMRNBioMarin Pharmaceutical, Inc. 0.87%89.014.3%$93.97m

Company Profile

Inmune Bio, Inc. is a clinical stage biotechnology company, which develops immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. Its products include INKMUNE and INB03. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.